Loading…
Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission
Soluble TLR2 levels are elevated in infective and inflammatory conditions, but its diagnostic value with sepsis-induced multi-organ failure has not been evaluated. 37 patients with a diagnosis of severe sepsis/septic shock (sepsis) and 27 patients with organ failure without infection (SIRS) were stu...
Saved in:
Published in: | Intensive care medicine experimental 2017-01, Vol.5 (1), p.2-2, Article 2 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c470t-2e3e46de70305287d618f167b71ea3bf26d34095fcdd53590832445a3e8398483 |
---|---|
cites | cdi_FETCH-LOGICAL-c470t-2e3e46de70305287d618f167b71ea3bf26d34095fcdd53590832445a3e8398483 |
container_end_page | 2 |
container_issue | 1 |
container_start_page | 2 |
container_title | Intensive care medicine experimental |
container_volume | 5 |
creator | Holst, Benjamin Szakmany, Tamas Raby, Anne-Catherine Hamlyn, Vincent Durno, Kimberley Hall, Judith E. Labéta, Mario O. |
description | Soluble TLR2 levels are elevated in infective and inflammatory conditions, but its diagnostic value with sepsis-induced multi-organ failure has not been evaluated. 37 patients with a diagnosis of severe sepsis/septic shock (sepsis) and 27 patients with organ failure without infection (SIRS) were studied. Median (IQR) plasma sTLR2 levels were 2.7 ng/ml (1.4–6.1) in sepsis and 0.6 ng/ml (0.4–0.9) in SIRS p < 0.001. sTLR2 showed good diagnostic value for sepsis at cut-off of 1.0 ng/ml, AUC:0.959. We report the ability of sTLR2 levels to discriminate between sepsis and SIRS within 12 h of ICU admission in patients with multi-organ failure. |
doi_str_mv | 10.1186/s40635-016-0116-z |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5236041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1861533332</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-2e3e46de70305287d618f167b71ea3bf26d34095fcdd53590832445a3e8398483</originalsourceid><addsrcrecordid>eNp1UdtqFTEUDaLYUvsBvkjAF19Gd66TeRHk4KVQ8MEWfAuZmT3npM2ZjMmM0n6Bn-G3-GXmeGo5CgZyYe-1VvZiEfKUwUvGjH6VJWihKmC67HLcPiDHnDV1Jbn6_PDgfUROc74CAAZK6AYekyNuoOFg4Jh8_xTD0gakFzGEKvhrpAk7nOaYKKc-U0dbH7cuXWOiQylmnHIp-5F2yc--cyHcUB8CndzscZwz_ebnDd0uYfZVTGs30sH5sCT83Sg8xn_-2NA40LPVJXX91ufs4_iEPBpcyHh6d5-Qy3dvL1YfqvOP789Wb86rTtYwVxwFSt1jDQIUN3WvmRmYrtuaoRPtwHUvJDRq6PpeCdWAEVxK5QQa0RhpxAl5vdedlnaLfVdGTi7YKfli8sZG5-3fndFv7Dp-tYoLDZIVgRd3Ail-WTDPtjjoMAQ3YlyyLdkwJcriBfr8H-hVXNJY7O1QijdMi7qg2B7VpZhzwuF-GAZ2F7XdR21L1HYXtb0tnGeHLu4Zf4ItAL4H5NIa15gOvv6v6i_GXbXn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1865291637</pqid></control><display><type>article</type><title>Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission</title><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>PubMed Central</source><creator>Holst, Benjamin ; Szakmany, Tamas ; Raby, Anne-Catherine ; Hamlyn, Vincent ; Durno, Kimberley ; Hall, Judith E. ; Labéta, Mario O.</creator><creatorcontrib>Holst, Benjamin ; Szakmany, Tamas ; Raby, Anne-Catherine ; Hamlyn, Vincent ; Durno, Kimberley ; Hall, Judith E. ; Labéta, Mario O.</creatorcontrib><description>Soluble TLR2 levels are elevated in infective and inflammatory conditions, but its diagnostic value with sepsis-induced multi-organ failure has not been evaluated. 37 patients with a diagnosis of severe sepsis/septic shock (sepsis) and 27 patients with organ failure without infection (SIRS) were studied. Median (IQR) plasma sTLR2 levels were 2.7 ng/ml (1.4–6.1) in sepsis and 0.6 ng/ml (0.4–0.9) in SIRS p < 0.001. sTLR2 showed good diagnostic value for sepsis at cut-off of 1.0 ng/ml, AUC:0.959. We report the ability of sTLR2 levels to discriminate between sepsis and SIRS within 12 h of ICU admission in patients with multi-organ failure.</description><identifier>ISSN: 2197-425X</identifier><identifier>EISSN: 2197-425X</identifier><identifier>DOI: 10.1186/s40635-016-0116-z</identifier><identifier>PMID: 28092080</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Critical Care Medicine ; Intensive ; Letter to the Editor ; Medicine ; Medicine & Public Health</subject><ispartof>Intensive care medicine experimental, 2017-01, Vol.5 (1), p.2-2, Article 2</ispartof><rights>The Author(s). 2017</rights><rights>Intensive Care Medicine Experimental is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-2e3e46de70305287d618f167b71ea3bf26d34095fcdd53590832445a3e8398483</citedby><cites>FETCH-LOGICAL-c470t-2e3e46de70305287d618f167b71ea3bf26d34095fcdd53590832445a3e8398483</cites><orcidid>0000-0003-3632-8844</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1865291637/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1865291637?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53770,53772,74873</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28092080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holst, Benjamin</creatorcontrib><creatorcontrib>Szakmany, Tamas</creatorcontrib><creatorcontrib>Raby, Anne-Catherine</creatorcontrib><creatorcontrib>Hamlyn, Vincent</creatorcontrib><creatorcontrib>Durno, Kimberley</creatorcontrib><creatorcontrib>Hall, Judith E.</creatorcontrib><creatorcontrib>Labéta, Mario O.</creatorcontrib><title>Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission</title><title>Intensive care medicine experimental</title><addtitle>ICMx</addtitle><addtitle>Intensive Care Med Exp</addtitle><description>Soluble TLR2 levels are elevated in infective and inflammatory conditions, but its diagnostic value with sepsis-induced multi-organ failure has not been evaluated. 37 patients with a diagnosis of severe sepsis/septic shock (sepsis) and 27 patients with organ failure without infection (SIRS) were studied. Median (IQR) plasma sTLR2 levels were 2.7 ng/ml (1.4–6.1) in sepsis and 0.6 ng/ml (0.4–0.9) in SIRS p < 0.001. sTLR2 showed good diagnostic value for sepsis at cut-off of 1.0 ng/ml, AUC:0.959. We report the ability of sTLR2 levels to discriminate between sepsis and SIRS within 12 h of ICU admission in patients with multi-organ failure.</description><subject>Critical Care Medicine</subject><subject>Intensive</subject><subject>Letter to the Editor</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><issn>2197-425X</issn><issn>2197-425X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1UdtqFTEUDaLYUvsBvkjAF19Gd66TeRHk4KVQ8MEWfAuZmT3npM2ZjMmM0n6Bn-G3-GXmeGo5CgZyYe-1VvZiEfKUwUvGjH6VJWihKmC67HLcPiDHnDV1Jbn6_PDgfUROc74CAAZK6AYekyNuoOFg4Jh8_xTD0gakFzGEKvhrpAk7nOaYKKc-U0dbH7cuXWOiQylmnHIp-5F2yc--cyHcUB8CndzscZwz_ebnDd0uYfZVTGs30sH5sCT83Sg8xn_-2NA40LPVJXX91ufs4_iEPBpcyHh6d5-Qy3dvL1YfqvOP789Wb86rTtYwVxwFSt1jDQIUN3WvmRmYrtuaoRPtwHUvJDRq6PpeCdWAEVxK5QQa0RhpxAl5vdedlnaLfVdGTi7YKfli8sZG5-3fndFv7Dp-tYoLDZIVgRd3Ail-WTDPtjjoMAQ3YlyyLdkwJcriBfr8H-hVXNJY7O1QijdMi7qg2B7VpZhzwuF-GAZ2F7XdR21L1HYXtb0tnGeHLu4Zf4ItAL4H5NIa15gOvv6v6i_GXbXn</recordid><startdate>20170113</startdate><enddate>20170113</enddate><creator>Holst, Benjamin</creator><creator>Szakmany, Tamas</creator><creator>Raby, Anne-Catherine</creator><creator>Hamlyn, Vincent</creator><creator>Durno, Kimberley</creator><creator>Hall, Judith E.</creator><creator>Labéta, Mario O.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3632-8844</orcidid></search><sort><creationdate>20170113</creationdate><title>Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission</title><author>Holst, Benjamin ; Szakmany, Tamas ; Raby, Anne-Catherine ; Hamlyn, Vincent ; Durno, Kimberley ; Hall, Judith E. ; Labéta, Mario O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-2e3e46de70305287d618f167b71ea3bf26d34095fcdd53590832445a3e8398483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Critical Care Medicine</topic><topic>Intensive</topic><topic>Letter to the Editor</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holst, Benjamin</creatorcontrib><creatorcontrib>Szakmany, Tamas</creatorcontrib><creatorcontrib>Raby, Anne-Catherine</creatorcontrib><creatorcontrib>Hamlyn, Vincent</creatorcontrib><creatorcontrib>Durno, Kimberley</creatorcontrib><creatorcontrib>Hall, Judith E.</creatorcontrib><creatorcontrib>Labéta, Mario O.</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Intensive care medicine experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holst, Benjamin</au><au>Szakmany, Tamas</au><au>Raby, Anne-Catherine</au><au>Hamlyn, Vincent</au><au>Durno, Kimberley</au><au>Hall, Judith E.</au><au>Labéta, Mario O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission</atitle><jtitle>Intensive care medicine experimental</jtitle><stitle>ICMx</stitle><addtitle>Intensive Care Med Exp</addtitle><date>2017-01-13</date><risdate>2017</risdate><volume>5</volume><issue>1</issue><spage>2</spage><epage>2</epage><pages>2-2</pages><artnum>2</artnum><issn>2197-425X</issn><eissn>2197-425X</eissn><abstract>Soluble TLR2 levels are elevated in infective and inflammatory conditions, but its diagnostic value with sepsis-induced multi-organ failure has not been evaluated. 37 patients with a diagnosis of severe sepsis/septic shock (sepsis) and 27 patients with organ failure without infection (SIRS) were studied. Median (IQR) plasma sTLR2 levels were 2.7 ng/ml (1.4–6.1) in sepsis and 0.6 ng/ml (0.4–0.9) in SIRS p < 0.001. sTLR2 showed good diagnostic value for sepsis at cut-off of 1.0 ng/ml, AUC:0.959. We report the ability of sTLR2 levels to discriminate between sepsis and SIRS within 12 h of ICU admission in patients with multi-organ failure.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>28092080</pmid><doi>10.1186/s40635-016-0116-z</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3632-8844</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2197-425X |
ispartof | Intensive care medicine experimental, 2017-01, Vol.5 (1), p.2-2, Article 2 |
issn | 2197-425X 2197-425X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5236041 |
source | Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access ; PubMed Central |
subjects | Critical Care Medicine Intensive Letter to the Editor Medicine Medicine & Public Health |
title | Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T16%3A39%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Soluble%20Toll-like%20receptor%202%20is%20a%20biomarker%20for%20sepsis%20in%20critically%20ill%20patients%20with%20multi-organ%20failure%20within%2012%C2%A0h%20of%20ICU%20admission&rft.jtitle=Intensive%20care%20medicine%20experimental&rft.au=Holst,%20Benjamin&rft.date=2017-01-13&rft.volume=5&rft.issue=1&rft.spage=2&rft.epage=2&rft.pages=2-2&rft.artnum=2&rft.issn=2197-425X&rft.eissn=2197-425X&rft_id=info:doi/10.1186/s40635-016-0116-z&rft_dat=%3Cproquest_pubme%3E1861533332%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c470t-2e3e46de70305287d618f167b71ea3bf26d34095fcdd53590832445a3e8398483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1865291637&rft_id=info:pmid/28092080&rfr_iscdi=true |